Tempest Therapeutics Inc (NASDAQ: TPST) is -80.68% lower on its value in year-to-date trading and has touched a low of $0.70 and a high of $6.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TPST stock was last observed hovering at around $0.85 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.86, the stock is 0.59% and -9.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.42 million and changing 1.20% at the moment leaves the stock -59.00% off its SMA200. TPST registered -77.98% loss for a year compared to 6-month loss of -60.64%. The firm has a 50-day simple moving average (SMA 50) of $0.95126 and a 200-day simple moving average (SMA200) of $2.1023.
The stock witnessed a -6.12% gain in the last 1 month and extending the period to 3 months gives it a -33.59%, and is 7.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.19% over the week and 8.63% over the month.
Tempest Therapeutics Inc (TPST) has around 17 employees, a market worth around $37.84M and $0.00M in sales. Distance from 52-week low is 22.65% and -85.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-178.81%).
The EPS is expected to grow by 29.53% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
30.0 institutions hold shares in Tempest Therapeutics Inc (TPST), with institutional investors hold 23.07% of the company’s shares. The shares outstanding are 43.64M, and float is at 39.62M with Short Float at 8.14%. Institutions hold 23.02% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.55 million shares valued at $1.21 million. The investor’s holdings represent 2.4747 of the TPST Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 0.43 million shares valued at $0.95 million to account for 1.9426 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 0.18 million shares representing 0.7924 and valued at over $0.39 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.6937 of the shares totaling 0.15 million with a market value of $0.34 million.
Tempest Therapeutics Inc (TPST) Insider Activity
Tempest Therapeutics Inc disclosed in a document filed with the SEC on Aug 08 ’24 that Versant Venture Capital VI, L. (10% Owner) sold a total of 400,000 shares of the company’s common stock. The trade occurred on Aug 08 ’24 and was made at $1.35 per share for $0.54 million. Following the transaction, the insider now directly holds 0.6 million shares of the TPST stock.
Still, SEC filings show that on Aug 12 ’24, Versant Venture Capital VI, L. (10% Owner) disposed off 387,999 shares at an average price of $1.10 for $0.43 million. The insider now directly holds 209,941 shares of Tempest Therapeutics Inc (TPST).
